Nimbus Therapeutics
Nimbus Therapeutics

Nimbus Therapeutics

Measured by AhrefsDR55Ahrefs DR: 55/100. Above median. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent39Agent Readiness: 39/100. Below median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed62Site Speed: 62/100. Above median. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust82Data Trust: 82/100. Top 25%. Measured by StartupHub.ai. Median 61.

Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.

2009ActiveBoston, United States

About

Nimbus Therapeutics is a clinical-stage biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery engine. They focus on precision small molecule design for targets implicated in multiple human diseases, including oncology, immunology, and metabolic disorders. Their approach combines cutting-edge computational chemistry, structural biology, and machine learning to accelerate the drug discovery and development process.

Key facts

Website
nimbustx.com
Headquarters
Boston, United States
Founded
2009
Total funding
$589M (Series F)
Business model
B2B

Funding rounds

Funding rounds raised by Nimbus Therapeutics
DateRoundAmountLead investors
6 Sept 2023Series F$210MGV (Google Ventures)
12 Sept 2022Series E$125M
13 Jul 2021Series D$105M
1 Jan 2020Series C$60M
1 Jan 2018Series B$65M
1 Jan 2011Seed$24M

Tech stack

Detected on nimbustx.com, last scanned 20 Oct 2026.

Analytics
Google Analytics 4, Segment, Microsoft Clarity
CMS / Builders
WordPress
Hosting
Google Cloud
Email provider
Mimecast

Nimbus Therapeutics scores 55. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is Nimbus Therapeutics trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Nimbus Therapeutics is 82 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Nimbus Therapeutics raised?

Nimbus Therapeutics has raised a total of $589M in funding. The most recent round on record is Series F.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for Nimbus Therapeutics